Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
- 1478.433
- -8.100-0.54%
Arcturus' Inhaled MRNA Therapeutic In Cystic Fibrosis Study Highlights Potential Amid Competitive Landscape: Analyst
Friday, Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) presented Phase 1 results in healthy volunteers and Phase 1b interim data in people with cystic fibrosis for ARCT-032, an inhaled investigation
Cathie Wood-Led Ark Invest Buys $9.9M Worth Of Amazon Shares, Also Picks Up Reddit Stock
On Thursday, Cathie Wood-led Ark Invest made significant trades in Amazon.com Inc (NASDAQ:AMZN) and Reddit Inc (NYSE:RDDT), amidst notable developments in both companies.The Amazon.com Trade: Ark Inve
$1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 5 years by 9.91% on an annualized basis producing an average annual return of 22.94%. Currently, Vertex Pharmaceuticals h
Top 4 Health Care Stocks That Are Preparing To Pump This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock's strength on days when prices go u
Cracking The Code: Understanding Analyst Reviews For Intellia Therapeutics
In the last three months, 4 analysts have published ratings on Intellia Therapeutics (NASDAQ:NTLA), offering a diverse range of perspectives from bullish to bearish.The following table summarizes thei
Intellia Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/04/2024 179.93% Cantor Fitzgerald $65 → $65 Reiterates Overweight → Overweight 05/10/2024 24.89% Citigr
Looking Into Agilent Technologies's Recent Short Interest
Agilent Technologies's (NYSE:A) short percent of float has fallen 9.94% since its last report. The company recently reported that it has 4.24 million shares sold short, which is 1.63% of all regular s
Cracking The Code: Understanding Analyst Reviews For Caribou Biosciences
During the last three months, 5 analysts shared their evaluations of Caribou Biosciences (NASDAQ:CRBU), revealing diverse outlooks from bullish to bearish.The table below provides a concise overview o
Caribou Biosciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/04/2024 322.54% HC Wainwright & Co. $24 → $9 Maintains Buy 05/16/2024 792.02% Truist Securities $19 → $
CN Energy Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
This Is What Whales Are Betting On Vertex Pharmaceuticals
Whales with a lot of money to spend have taken a noticeably bullish stance on Vertex Pharmaceuticals.Looking at options history for Vertex Pharmaceuticals (NASDAQ:VRTX) we detected 16 trades.If we con
$1000 Invested In This Stock 15 Years Ago Would Be Worth $6,700 Today
Agilent Technologies (NYSE:A) has outperformed the market over the past 15 years by 1.39% on an annualized basis producing an average annual return of 13.49%. Currently, Agilent Technologies has a mar
12 Health Care Stocks Moving In Monday's Intraday Session
GainersStructure Therapeutics (NASDAQ:GPCR) stock moved upwards by 71.0% to $58.47 during Monday's regular session. The market value of their outstanding shares is at $2.7 billion. Concord Medical Ser
Why Intellia Therapeutics Shares Are Trading Higher Monday
Intellia Therapeutics, Inc. (NASDAQ:NTLA) stock is moving higher Monday after the company announced long-term data from its Phase 1 Study of NTLA-2002.The Details: Intellia's NTLA-2002 is an experimen
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Monday.Shares of Stericycle, Inc. (NASDAQ:SRCL) rose sharply during Monday's session after the company inked a deal to be
Intellia Rallies on Phase 1 Data for CRISPR-based HAE Therapy
Caribou Stock Plunges 30% Amid Study Update, Evercore Downgrade
Jefferies Downgrades Agilent Technologies to Hold, Lowers Price Target to $135
Jefferies analyst Brandon Couillard downgrades Agilent Technologies (NYSE:A) from Buy to Hold and lowers the price target from $152 to $135.
Market-Moving News for June 3rd
GME: 103% | 'Roaring Kitty' Reveals Massive GME Position On Reddit, Including $65M Call Options: Is He Bringing 'Courage' Back To Wall Street?BPTH: 81% | Bio-Path Presented Interim Results From Phase
Salesforce And Celsius Were Among The 10 Biggest Large Cap Losers Last Week: Are These In Your Portfolio?
These ten large-cap stocks were the worst performers in the last week. Are they in your portfolio?MongoDB, Inc. (NASDAQ:MDB) shares tumbled 31.63% after the company issued weak Q2 and FY25 guidance. A